Vagus nerve stimulation (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vagus nerve stimulation" in English language version.

refsWebsite

Global rank English rank

124nih.gov

4^th place

93doi.org

2^nd place

30semanticscholar.org

11^th place

8^th place

12worldcat.org

5^th place

3nice.org.uk

3,258^th place

2,666^th place

3web.archive.org

1^st place

3medscape.com

719^th place

636^th place

3fda.gov

447^th place

338^th place

2handle.net

102^nd place

76^th place

2sciencedirect.com

149^th place

178^th place

1electrocore.com

low place

1harvard.edu

18^th place

17^th place

1unil.ch

9,112^th place

7,304^th place

1gammacore.com

low place

1washingtonpost.com

34^th place

27^th place

1ieee.org

652^nd place

515^th place

1srce.hr

1,922^nd place

1scientificamerican.com

896^th place

674^th place

1medpagetoday.com

9,274^th place

5,856^th place

1neurologylive.com

low place

doi.org

Badran BW, Austelle CW (January 2022). "The Future Is Noninvasive: A Brief Review of the Evolution and Clinical Utility of Vagus Nerve Stimulation". Focus. 20 (1): 3–7. doi:10.1176/appi.focus.20210023. PMC 9063597. PMID 35746934.
Badran BW, Austelle CW (January 2022). "The Future Is Noninvasive: A Brief Review of the Evolution and Clinical Utility of Vagus Nerve Stimulation". Focus. 20 (1): 3–7. doi:10.1176/appi.focus.20210023. PMC 9063597. PMID 35746934.
Johnson RL, Wilson CG (May 2018). "A review of vagus nerve stimulation as a therapeutic intervention". Journal of Inflammation Research. 11: 203–213. doi:10.2147/JIR.S163248. PMC 5961632. PMID 29844694.
Panebianco M, Rigby A, Marson AG (July 2022). "Vagus nerve stimulation for focal seizures". The Cochrane Database of Systematic Reviews. 2022 (7): CD002896. doi:10.1002/14651858.CD002896.pub3. PMC 9281624. PMID 35833911.
Howland RH (June 2014). "Vagus Nerve Stimulation". Current Behavioral Neuroscience Reports. 1 (2): 64–73. doi:10.1007/s40473-014-0010-5. PMC 4017164. PMID 24834378.
Yuan H, Silberstein SD (February 2016). "Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part II". Headache. 56 (2): 259–266. doi:10.1111/head.12650. PMID 26381725.
Wheless JW, Gienapp AJ, Ryvlin P (November 2018). "Vagus nerve stimulation (VNS) therapy update". Epilepsy & Behavior. 88S: 2–10. doi:10.1016/j.yebeh.2018.06.032. PMID 30017839. S2CID 51679627.
Morris GL, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C (October 2013). "Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology". Neurology. 81 (16): 1453–1459. doi:10.1212/wnl.0b013e3182a393d1. PMC 3806910. PMID 23986299.
Fisher RS, Handforth A (September 1999). "Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology". Neurology. 53 (4): 666–669. doi:10.1212/wnl.53.4.666. PMID 10489023. S2CID 20845641.
Helmers SL, Duh MS, Guérin A, Sarda SP, Samuelson TM, Bunker MT, et al. (October 2011). "Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy". Epilepsy & Behavior. 22 (2): 370–375. doi:10.1016/j.yebeh.2011.07.020. PMID 21872534. S2CID 7869407.
Grioni D, Landi A (January 2019). "Does Vagal Nerve Stimulation Treat Drug-Resistant Epilepsy in Patients with Tuberous Sclerosis Complex?". World Neurosurgery. 121: 251–253. doi:10.1016/j.wneu.2018.10.077. PMID 30347295. S2CID 53034756.
Braakman HM, Creemers J, Hilkman DM, Klinkenberg S, Koudijs SM, Debeij-van Hall M, et al. (2018). "Improved seizure control and regaining cognitive milestones after vagus nerve stimulation revision surgery in Lennox-Gastaut syndrome". Epilepsy & Behavior Case Reports. 10: 111–113. doi:10.1016/j.ebcr.2018.08.002. PMC 6197149. PMID 30364578.
Arya R, Greiner HM, Lewis A, Mangano FT, Gonsalves C, Holland KD, et al. (May 2013). "Vagus nerve stimulation for medically refractory absence epilepsy". Seizure. 22 (4): 267–270. doi:10.1016/j.seizure.2013.01.008. PMID 23391567. S2CID 14917920.
Rolston JD, Englot DJ, Wang DD, Garcia PA, Chang EF (October 2015). "Corpus callosotomy versus vagus nerve stimulation for atonic seizures and drop attacks: A systematic review". Epilepsy & Behavior. 51: 13–17. doi:10.1016/j.yebeh.2015.06.001. PMC 5261864. PMID 26247311.
Dibué-Adjei M, Brigo F, Yamamoto T, Vonck K, Trinka E (September 2019). "Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review". Brain Stimulation. 12 (5): 1101–1110. doi:10.1016/j.brs.2019.05.011. PMID 31126871. S2CID 153310356.
Peng KP, Burish MJ (2023-08-01). "Management of cluster headache: Treatments and their mechanisms". Cephalalgia. 43 (8): 03331024231196808. doi:10.1177/03331024231196808. ISSN 0333-1024. PMID 37652457.
Silberstein SD, Mechtler LL, Kudrow DB, Calhoun AH, McClure C, Saper JR, et al. (2016). "Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study". Headache: The Journal of Head and Face Pain. 56 (8): 1317–1332. doi:10.1111/head.12896. ISSN 1526-4610. PMC 5113831. PMID 27593728.
Goadsby PJ, de Coo IF, Silver N, Tyagi A, Ahmed F, Gaul C, et al. (2018-04-01). "Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study". Cephalalgia. 38 (5): 959–969. doi:10.1177/0333102417744362. ISSN 0333-1024. PMC 5896689. PMID 29231763.
Carreno FR, Frazer A (July 2017). "Vagal Nerve Stimulation for Treatment-Resistant Depression". Neurotherapeutics. 14 (3): 716–727. doi:10.1007/s13311-017-0537-8. PMC 5509631. PMID 28585221.
Shao P, Li H, Jiang J, Guan Y, Chen X, Wang Y (2023). "Role of Vagus Nerve Stimulation in the Treatment of Chronic Pain". Neuroimmunomodulation. 30 (1): 167–183. doi:10.1159/000531626. PMC 10614462. PMID 37369181.
Capilupi MJ, Kerath SM, Becker LB (February 2020). "Vagus Nerve Stimulation and the Cardiovascular System". Cold Spring Harbor Perspectives in Medicine. 10 (2): a034173. doi:10.1101/cshperspect.a034173. PMC 6996447. PMID 31109966.
Andalib S, Divani AA, Ayata C, Baig S, Arsava EM, Topcuoglu MA, et al. (December 2023). "Vagus Nerve Stimulation in Ischemic Stroke". Current Neurology and Neuroscience Reports. 23 (12): 947–962. doi:10.1007/s11910-023-01323-w. PMC 10841711. PMID 38008851.
Liu CY, Russin J, Adelson DP, Jenkins A, Hilmi O, Brown B, et al. (November 2022). "Vagus nerve stimulation paired with rehabilitation for stroke: Implantation experience from the VNS-REHAB trial". Journal of Clinical Neuroscience. 105: 122–128. doi:10.1016/j.jocn.2022.09.013. PMID 36182812.
Englot DJ, Chang EF, Auguste KI (December 2011). "Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response". Journal of Neurosurgery. 115 (6): 1248–1255. doi:10.3171/2011.7.JNS11977. PMID 21838505.
Chrastina J, Novák Z, Zeman T, Kočvarová J, Pail M, Doležalová I, et al. (July 2018). "Single-center long-term results of vagus nerve stimulation for epilepsy: A 10-17 year follow-up study". Seizure. 59: 41–47. doi:10.1016/j.seizure.2018.04.022. PMID 29738985. S2CID 13700901.
Englot DJ, Rolston JD, Wright CW, Hassnain KH, Chang EF (September 2016). "Rates and Predictors of Seizure Freedom With Vagus Nerve Stimulation for Intractable Epilepsy". Neurosurgery. 79 (3): 345–353. doi:10.1227/NEU.0000000000001165. PMC 4884552. PMID 26645965.
Englot DJ, Hassnain KH, Rolston JD, Harward SC, Sinha SR, Haglund MM (January 2017). "Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data". Epilepsy & Behavior. 66: 4–9. doi:10.1016/j.yebeh.2016.10.005. PMC 5258831. PMID 27974275.
Ryvlin P, So EL, Gordon CM, Hesdorffer DC, Sperling MR, Devinsky O, et al. (March 2018). "Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapy". Epilepsia. 59 (3): 562–572. doi:10.1111/epi.14002. PMID 29336017. S2CID 3782079.
Englot DJ, Rolston JD, Wang DD, Hassnain KH, Gordon CM, Chang EF (November 2012). "Efficacy of vagus nerve stimulation in posttraumatic versus nontraumatic epilepsy". Journal of Neurosurgery. 117 (5): 970–977. doi:10.3171/2012.8.jns122. PMID 22978542.
Lam J, Williams M, Ashla M, Lee DJ (May 2021). "Cognitive outcomes following vagus nerve stimulation, responsive neurostimulation and deep brain stimulation for epilepsy: A systematic review". Epilepsy Research. 172: 106591. doi:10.1016/j.eplepsyres.2021.106591. PMID 33711711. S2CID 231956548.
Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D, et al. (October 2014). "Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children". Epilepsia. 55 (10): 1576–1584. doi:10.1111/epi.12762. PMID 25231724. S2CID 25790247.
Reif-Leonhard C, Reif A, Baune BT, Kavakbasi E (September 2022). "[Vagus nerve stimulation for difficult to treat depression]". Der Nervenarzt. 93 (9): 921–930. doi:10.1007/s00115-022-01282-6. PMC 9452433. PMID 35380222.
Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, et al. (September 2005). "Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial". Biological Psychiatry. 58 (5): 347–354. doi:10.1016/j.biopsych.2005.05.025. PMID 16139580.
Assenza G, Tombini M, Lanzone J, Ricci L, Di Lazzaro V, Casciato S, et al. (November 2020). "Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review". Neurological Sciences. 41 (11): 3075–3084. doi:10.1007/s10072-020-04479-2. hdl:11380/1207095. PMID 32524324. S2CID 219567684.
Aaronson ST, Carpenter LL, Conway CR, Reimherr FW, Lisanby SH, Schwartz TL, et al. (July 2013). "Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects". Brain Stimulation. 6 (4): 631–640. doi:10.1016/j.brs.2012.09.013. PMID 23122916.
Arredondo K, Patel AD (2023). "Quality of life, neurocognitive outcomes, and mood effects with neurostimulation devices". Neurostimulation for Epilepsy. pp. 229–244. doi:10.1016/B978-0-323-91702-5.00004-9. ISBN 978-0-323-91702-5.
Schachter SC (February 2004). "Vagus nerve stimulation: mood and cognitive effects". Epilepsy & Behavior. 5 Suppl 1: S56 – S59. doi:10.1016/j.yebeh.2003.11.007. PMID 14725847.
Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE (December 2000). "Vagus nerve stimulation is associated with mood improvements in epilepsy patients". Epilepsy Research. 42 (2–3): 203–210. doi:10.1016/s0920-1211(00)00181-9. PMID 11074193.
Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, Labar DR (April 2000). "A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation". Epilepsy & Behavior. 1 (2): 93–99. doi:10.1006/ebeh.2000.0046. PMID 12609137.
Hoppe C, Helmstaedter C, Scherrmann J, Elger CE (August 2001). "Self-Reported Mood Changes following 6 Months of Vagus Nerve Stimulation in Epilepsy Patients". Epilepsy & Behavior. 2 (4): 335–342. doi:10.1006/ebeh.2001.0194. PMID 12609210. S2CID 22552070.
Fan JJ, Shan W, Wu JP, Wang Q (November 2019). "Research progress of vagus nerve stimulation in the treatment of epilepsy". CNS Neuroscience & Therapeutics. 25 (11): 1222–1228. doi:10.1111/cns.13209. PMC 6834923. PMID 31429206.
Ryvlin P, Gilliam FG, Nguyen DK, Colicchio G, Iudice A, Tinuper P, et al. (June 2014). "The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial". Epilepsia. 55 (6): 893–900. doi:10.1111/epi.12611. PMC 4283995. PMID 24754318.
Knorr C, Greuter L, Constantini S, Fried I, Kremer U, Datta AN, et al. (January 2021). "Subgroup analysis of seizure and cognitive outcome after vagal nerve stimulator implantation in children". Child's Nervous System. 37 (1): 243–252. doi:10.1007/s00381-020-04628-0. PMID 32361930. S2CID 218467172.
Tornero C, Pastor E, Garzando Md, Orduña J, Forner MJ, Bocigas I, et al. (2022-04-08). "Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I)". Frontiers in Neurology. 13. doi:10.3389/fneur.2022.820864. ISSN 1664-2295. PMC 9028764. PMID 35463130.
Khan MW, Ahmad M, Qudrat S, Afridi F, Khan NA, Afridi Z, et al. (2024-12-01). "Vagal nerve stimulation for the management of long COVID symptoms". Infectious Medicine. 3 (4): 100149. doi:10.1016/j.imj.2024.100149. ISSN 2772-431X. PMC 11638592. PMID 39678231.
Tarn J, Evans E, Traianos E, Collins A, Stylianou M, Parikh J, et al. (April 2023). "The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's Syndrome". Neuromodulation. 26 (3): 681–689. doi:10.1016/j.neurom.2022.08.461. PMID 37032583. S2CID 253172246.
Sahn B, Pascuma K, Kohn N, Tracey KJ, Markowitz JF (October 2023). "Transcutaneous auricular vagus nerve stimulation attenuates inflammatory bowel disease in children: a proof-of-concept clinical trial". Bioelectronic Medicine. 9 (1): 23. doi:10.1186/s42234-023-00124-3. PMC 10583463. PMID 37849000.
Mac CH, Tai HM, Huang SM, Peng HH, Sharma AK, Nguyen GL, et al. (May 2024). "Orally Ingested Self-Powered Stimulators for Targeted Gut-Brain Axis Electrostimulation to Treat Obesity and Metabolic Disorders". Advanced Materials. 36 (21): e2310351. Bibcode:2024AdM....3610351M. doi:10.1002/adma.202310351. PMID 38591658.
Fraschini M, Puligheddu M, Demuru M, Polizzi L, Maleci A, Tamburini G, et al. (March 2013). "VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy". Neuroscience Letters. 536: 14–18. doi:10.1016/j.neulet.2012.12.044. hdl:11380/1331383. PMID 23333601. S2CID 25790383.
Sangare A, Marchi A, Pruvost-Robieux E, Soufflet C, Crepon B, Ramdani C, et al. (December 2020). "The Effectiveness of Vagus Nerve Stimulation in Drug-Resistant Epilepsy Correlates with Vagus Nerve Stimulation-Induced Electroencephalography Desynchronization". Brain Connectivity. 10 (10): 566–577. doi:10.1089/brain.2020.0798. PMC 7757623. PMID 33073582.
Joseph NM, Steffan P, Becker D, Wernovsky M, Datta P, Ernst L (June 2022). "Effects of VNS stimulation on electrocorticography in patients with dual neuro- stimulation devices". Journal of Neurology, Neurosurgery & Psychiatry. 93 (6): A3.3–A4. doi:10.1136/jnnp-2022-abn.9. S2CID 249067601.
Paudel YN, Shaikh MF, Shah S, Kumari Y, Othman I (October 2018). "Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy". European Journal of Pharmacology. 837: 145–155. doi:10.1016/j.ejphar.2018.08.020. PMID 30125565. S2CID 52048111.
Wang Y, Zhan G, Cai Z, Jiao B, Zhao Y, Li S, et al. (August 2021). "Vagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms". Neuroscience and Biobehavioral Reviews. 127: 37–53. doi:10.1016/j.neubiorev.2021.04.018. PMID 33894241. S2CID 233328858.
Manta S, El Mansari M, Debonnel G, Blier P (March 2013). "Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems". The International Journal of Neuropsychopharmacology. 16 (2): 459–470. doi:10.1017/s1461145712000387. PMID 22717062.
Furmaga H, Shah A, Frazer A (November 2011). "Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats". Biological Psychiatry. 70 (10): 937–945. doi:10.1016/j.biopsych.2011.07.020. PMID 21907323. S2CID 206101850.
Fornai F, Ruffoli R, Giorgi FS, Paparelli A (June 2011). "The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulation". The European Journal of Neuroscience. 33 (12): 2169–2178. doi:10.1111/j.1460-9568.2011.07707.x. ISSN 1460-9568. PMID 21535457.
Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, et al. (November 2020). "Locus coeruleus: a new look at the blue spot". Nature Reviews Neuroscience. 21 (11): 644–659. doi:10.1038/s41583-020-0360-9. ISSN 1471-0048. PMC 8991985. PMID 32943779.
Berger A, Vespa S, Dricot L, Dumoulin M, Iachim E, Doguet P, et al. (2021). "How Is the Norepinephrine System Involved in the Antiepileptic Effects of Vagus Nerve Stimulation?". Frontiers in Neuroscience. 15: 790943. doi:10.3389/fnins.2021.790943. ISSN 1662-4548. PMC 8675889. PMID 34924947.
Rodenkirch C, Carmel JB, Wang Q (2022-07-05). "Rapid Effects of Vagus Nerve Stimulation on Sensory Processing Through Activation of Neuromodulatory Systems". Frontiers in Neuroscience. 16. doi:10.3389/fnins.2022.922424. ISSN 1662-453X. PMC 9294458. PMID 35864985.
Breit S, Kupferberg A, Rogler G, Hasler G (2018). "Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders". Frontiers in Psychiatry. 9: 44. doi:10.3389/fpsyt.2018.00044. PMC 5859128. PMID 29593576.
Tarn J, Evans E, Traianos E, Collins A, Stylianou M, Parikh J, et al. (April 2023). "The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's Syndrome". Neuromodulation. 26 (3): 681–689. doi:10.1016/j.neurom.2022.08.461. PMID 37032583.
Faraji N, Payami B, Ebadpour N, Gorji A (2025-02-01). "Vagus nerve stimulation and gut microbiota interactions: A novel therapeutic avenue for neuropsychiatric disorders". Neuroscience & Biobehavioral Reviews. 169: 105990. doi:10.1016/j.neubiorev.2024.105990. ISSN 0149-7634. PMID 39716559.
Faraji N, Payami B, Ebadpour N, Gorji A (2025-02-01). "Vagus nerve stimulation and gut microbiota interactions: A novel therapeutic avenue for neuropsychiatric disorders". Neuroscience & Biobehavioral Reviews. 169: 105990. doi:10.1016/j.neubiorev.2024.105990. ISSN 0149-7634. PMID 39716559.
Révész D, Rydenhag B, Ben-Menachem E (July 2016). "Complications and safety of vagus nerve stimulation: 25 years of experience at a single center". Journal of Neurosurgery. Pediatrics. 18 (1): 97–104. doi:10.3171/2016.1.peds15534. PMID 27015521.
Révész D, Rydenhag B, Ben-Menachem E (July 2016). "Complications and safety of vagus nerve stimulation: 25 years of experience at a single center". Journal of Neurosurgery. Pediatrics. 18 (1): 97–104. doi:10.1016/j.ijporl.2023.111603. PMID 27015521.
Coughlin MK (October 2001). "Long-Term Treatment with Vagus Nerve Stimulation in Patients with Refractory Epilepsy". AORN Journal. 74 (4): 554. doi:10.1016/s0001-2092(06)61692-x.
Salvadé A, Ryvlin P, Rossetti AO (February 2018). "Impact of vagus nerve stimulation on sleep-related breathing disorders in adults with epilepsy". Epilepsy & Behavior. 79: 126–129. doi:10.1016/j.yebeh.2017.10.040. PMID 29287215. S2CID 46769980.
Aihua L, Lu S, Liping L, Xiuru W, Hua L, Yuping W (October 2014). "A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy". Epilepsy & Behavior. 39: 105–110. doi:10.1016/j.yebeh.2014.08.005. ISSN 1525-5069. PMID 25240121.
Edwards CA, Kouzani A, Lee KH, Ross EK (September 2017). "Neurostimulation Devices for the Treatment of Neurologic Disorders". Mayo Clinic Proceedings. 92 (9): 1427–1444. doi:10.1016/j.mayocp.2017.05.005. PMID 28870357.
Giordano F, Zicca A, Barba C, Guerrini R, Genitori L (April 2017). "Vagus nerve stimulation: Surgical technique of implantation and revision and related morbidity". Epilepsia. 58 Suppl 1 (Suppl 1): 85–90. doi:10.1111/epi.13678. PMID 28386925.
Butt MF, Albusoda A, Farmer AD, Aziz Q (April 2020). "The anatomical basis for transcutaneous auricular vagus nerve stimulation". Journal of Anatomy. 236 (4): 588–611. doi:10.1111/joa.13122. PMC 7083568. PMID 31742681.
Lanska DJ (February 2002). "J.L. Corning and vagal nerve stimulation for seizures in the 1880s". Neurology. 58 (3): 452–459. doi:10.1212/wnl.58.3.452. PMID 11839848.
Bailey P, Bremer F (September 1938). "A Sensory Cortical Representation of the Vagus Nerve: With a Note on the Effects of Low Blood Pressure on the Cortical Electrogram". Journal of Neurophysiology. 1 (5): 405–412. doi:10.1152/jn.1938.1.5.405.
George MS, Sackeim HA, Rush AJ, Marangell LB, Nahas Z, Husain MM, et al. (February 2000). "Vagus nerve stimulation: a new tool for brain research and therapy". Biological Psychiatry. 47 (4): 287–295. doi:10.1016/s0006-3223(99)00308-x. PMID 10686263. S2CID 14489190.
Zabara J (September 1985). "Peripheral control of hypersynchronous discharge in epilepsy". Electroencephalography and Clinical Neurophysiology. 61 (3): S162. doi:10.1016/0013-4694(85)90626-1.
Zabara J (November 1992). "Inhibition of experimental seizures in canines by repetitive vagal stimulation". Epilepsia. 33 (6): 1005–1012. doi:10.1111/j.1528-1157.1992.tb01751.x. PMID 1464256. S2CID 19290172.
Penry JK, Dean JC (June 1990). "Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results". Epilepsia. 31 Suppl 2 (s2): S40 – S43. doi:10.1111/j.1528-1157.1990.tb05848.x. PMID 2121469. S2CID 32134763.
Groves DA, Brown VJ (May 2005). "Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects". Neuroscience and Biobehavioral Reviews. 29 (3): 493–500. doi:10.1016/j.neubiorev.2005.01.004. PMID 15820552. S2CID 3021573.
de Lartigue G (October 2016). "Role of the vagus nerve in the development and treatment of diet-induced obesity". The Journal of Physiology. 594 (20): 5791–5815. doi:10.1113/JP271538. PMC 5063945. PMID 26959077.
Göbel CH, Tronnier VM, Münte TF (December 2017). "Brain stimulation in obesity". International Journal of Obesity. 41 (12): 1721–1727. doi:10.1038/ijo.2017.150. PMID 28663570. S2CID 20426017.
Abraham WT, Smith SA (February 2013). "Devices in the management of advanced, chronic heart failure". Nature Reviews. Cardiology. 10 (2): 98–110. doi:10.1038/nrcardio.2012.178. PMC 3753073. PMID 23229137.
Sabbah HN (August 2011). "Electrical vagus nerve stimulation for the treatment of chronic heart failure". Cleveland Clinic Journal of Medicine. 78 Suppl 1 (1): S24 – S29. doi:10.3949/ccjm.78.s1.04. PMC 3817894. PMID 21972326.
Koopman FA, van Maanen MA, Vervoordeldonk MJ, Tak PP (July 2017). "Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis". Journal of Internal Medicine. 282 (1): 64–75. doi:10.1111/joim.12626. PMID 28547815.
Bonaz B, Sinniger V, Pellissier S (2021). "Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases". Frontiers in Neuroscience. 15: 650971. doi:10.3389/fnins.2021.650971. PMC 8019822. PMID 33828455.
Payne SC, Furness JB, Burns O, Sedo A, Hyakumura T, Shepherd RK, et al. (2019). "Anti-inflammatory Effects of Abdominal Vagus Nerve Stimulation on Experimental Intestinal Inflammation". Frontiers in Neuroscience. 13: 418. doi:10.3389/fnins.2019.00418. PMC 6517481. PMID 31133776.
Merrill CA, Jonsson MA, Minthon L, Ejnell H, C-son Silander H, Blennow K, et al. (August 2006). "Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year". The Journal of Clinical Psychiatry. 67 (8): 1171–1178. doi:10.4088/jcp.v67n0801. PMID 16965193.
Broncel A, Bocian R, Kłos-Wojtczak P, Kulbat-Warycha K, Konopacki J (February 2020). "Vagal nerve stimulation as a promising tool in the improvement of cognitive disorders". Brain Research Bulletin. 155: 37–47. doi:10.1016/j.brainresbull.2019.11.011. PMID 31790720. S2CID 208344249.
Gierthmuehlen M, Plachta DT (February 2016). "Effect of selective vagal nerve stimulation on blood pressure, heart rate and respiratory rate in rats under metoprolol medication". Hypertension Research. 39 (2): 79–87. doi:10.1038/hr.2015.122. PMID 26581776. S2CID 21184892.
Annoni EM, Van Helden D, Guo Y, Levac B, Libbus I, KenKnight BH, et al. (31 January 2019). "Chronic Low-Level Vagus Nerve Stimulation Improves Long-Term Survival in Salt-Sensitive Hypertensive Rats". Frontiers in Physiology. 10: 25. doi:10.3389/fphys.2019.00025. PMC 6365472. PMID 30766489.
Chakravarthy K, Chaudhry H, Williams K, Christo PJ (December 2015). "Review of the Uses of Vagal Nerve Stimulation in Chronic Pain Management". Current Pain and Headache Reports. 19 (12): 54. doi:10.1007/s11916-015-0528-6. PMID 26493698. S2CID 8117776.
Johnson RL, Wilson CG (2018). "A review of vagus nerve stimulation as a therapeutic intervention". Journal of Inflammation Research. 11: 203–213. doi:10.2147/JIR.S163248. PMC 5961632. PMID 29844694.
Puledda F, Goadsby PJ (April 2017). "An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine". Headache. 57 (4): 685–691. doi:10.1111/head.13069. PMID 28295242. S2CID 205161411.
Yesiltepe M, Cimen B, Sara Y (September 2022). "Effects of chronic vagal nerve stimulation in the treatment of β-amyloid-induced neuropsychiatric symptoms". European Journal of Pharmacology. 931: 175179. doi:10.1016/j.ejphar.2022.175179. PMID 35973478. S2CID 251558829.

electrocore.com

"gammaCore® Receives FDA Clearance for the Acute Treatment of Pain Associated with Migraine Headache in Adult Patients". electroCore. Retrieved 2025-02-25.

fda.gov

accessdata.fda.gov

"GammaCore Device Classification under Section 513(f)(2)(de novo)". FDA. Retrieved 6 June 2018.
"GammaCore 510(k) Premarket Notification". FDA. Archived from the original on November 11, 2020. Retrieved 6 June 2018.

fda.gov

"FDA Approves First-of-Its-Kind Stroke Rehabilitation System". Food and Drug Administration. 31 August 2021. Archived from the original on August 27, 2021.

gammacore.com

https://www.gammacore.com/wp-content/uploads/2022/10/gammaCore-Sapphire-SLC-IFU.pdf

handle.net

hdl.handle.net

Assenza G, Tombini M, Lanzone J, Ricci L, Di Lazzaro V, Casciato S, et al. (November 2020). "Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review". Neurological Sciences. 41 (11): 3075–3084. doi:10.1007/s10072-020-04479-2. hdl:11380/1207095. PMID 32524324. S2CID 219567684.
Fraschini M, Puligheddu M, Demuru M, Polizzi L, Maleci A, Tamburini G, et al. (March 2013). "VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy". Neuroscience Letters. 536: 14–18. doi:10.1016/j.neulet.2012.12.044. hdl:11380/1331383. PMID 23333601. S2CID 25790383.

harvard.edu

ui.adsabs.harvard.edu

Mac CH, Tai HM, Huang SM, Peng HH, Sharma AK, Nguyen GL, et al. (May 2024). "Orally Ingested Self-Powered Stimulators for Targeted Gut-Brain Axis Electrostimulation to Treat Obesity and Metabolic Disorders". Advanced Materials. 36 (21): e2310351. Bibcode:2024AdM....3610351M. doi:10.1002/adma.202310351. PMID 38591658.

ieee.org

spectrum.ieee.org

Moore SK (22 July 2020). "Handheld Vagus Nerve Stimulator Gets Emergency Approval for COVID-19 Use". IEEE Spectrum.

medpagetoday.com

Hamza Z (15 December 2021). "Non-Invasive Nerve Stimulation Shows Promise for Younger IBD Patients". Medpage Today.

medscape.com

Kron T (5 May 2022). "Vagus Nerve Stimulation: A Little-Known Option for Depression". Medscape.
Brauser D (April 18, 2017). "FDA Approves Vagus Nerve Stimulation Device for Cluster Headache". Medscape.
Brauser D (January 29, 2018). "FDA Clears Vagus Nerve Stimulator for Migraine Pain". Medscape.

neurologylive.com

Meglio M (3 June 2021). "Noninvasive Vagus Nerve Stimulation for Parkinson Disease Shows Safety, Efficacy". Neurology live.

nice.org.uk

"The Nurosym/Parasym". www.nice.org.uk.
"1 Recommendations | Implanted vagus nerve stimulation for treatment-resistant depression | Guidance | NICE". 12 August 2020.
"Medical technology guidance SCOPE - gammaCore for cluster headache". www.nice.org.uk.

nih.gov

pubmed.ncbi.nlm.nih.gov

Badran BW, Austelle CW (January 2022). "The Future Is Noninvasive: A Brief Review of the Evolution and Clinical Utility of Vagus Nerve Stimulation". Focus. 20 (1): 3–7. doi:10.1176/appi.focus.20210023. PMC 9063597. PMID 35746934.
Badran BW, Austelle CW (January 2022). "The Future Is Noninvasive: A Brief Review of the Evolution and Clinical Utility of Vagus Nerve Stimulation". Focus. 20 (1): 3–7. doi:10.1176/appi.focus.20210023. PMC 9063597. PMID 35746934.
Johnson RL, Wilson CG (May 2018). "A review of vagus nerve stimulation as a therapeutic intervention". Journal of Inflammation Research. 11: 203–213. doi:10.2147/JIR.S163248. PMC 5961632. PMID 29844694.
Panebianco M, Rigby A, Marson AG (July 2022). "Vagus nerve stimulation for focal seizures". The Cochrane Database of Systematic Reviews. 2022 (7): CD002896. doi:10.1002/14651858.CD002896.pub3. PMC 9281624. PMID 35833911.
Howland RH (June 2014). "Vagus Nerve Stimulation". Current Behavioral Neuroscience Reports. 1 (2): 64–73. doi:10.1007/s40473-014-0010-5. PMC 4017164. PMID 24834378.
Yuan H, Silberstein SD (February 2016). "Vagus Nerve and Vagus Nerve Stimulation, a Comprehensive Review: Part II". Headache. 56 (2): 259–266. doi:10.1111/head.12650. PMID 26381725.
Wheless JW, Gienapp AJ, Ryvlin P (November 2018). "Vagus nerve stimulation (VNS) therapy update". Epilepsy & Behavior. 88S: 2–10. doi:10.1016/j.yebeh.2018.06.032. PMID 30017839. S2CID 51679627.
Morris GL, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C (October 2013). "Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology". Neurology. 81 (16): 1453–1459. doi:10.1212/wnl.0b013e3182a393d1. PMC 3806910. PMID 23986299.
Fisher RS, Handforth A (September 1999). "Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology". Neurology. 53 (4): 666–669. doi:10.1212/wnl.53.4.666. PMID 10489023. S2CID 20845641.
Helmers SL, Duh MS, Guérin A, Sarda SP, Samuelson TM, Bunker MT, et al. (October 2011). "Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy". Epilepsy & Behavior. 22 (2): 370–375. doi:10.1016/j.yebeh.2011.07.020. PMID 21872534. S2CID 7869407.
Grioni D, Landi A (January 2019). "Does Vagal Nerve Stimulation Treat Drug-Resistant Epilepsy in Patients with Tuberous Sclerosis Complex?". World Neurosurgery. 121: 251–253. doi:10.1016/j.wneu.2018.10.077. PMID 30347295. S2CID 53034756.
Braakman HM, Creemers J, Hilkman DM, Klinkenberg S, Koudijs SM, Debeij-van Hall M, et al. (2018). "Improved seizure control and regaining cognitive milestones after vagus nerve stimulation revision surgery in Lennox-Gastaut syndrome". Epilepsy & Behavior Case Reports. 10: 111–113. doi:10.1016/j.ebcr.2018.08.002. PMC 6197149. PMID 30364578.
Arya R, Greiner HM, Lewis A, Mangano FT, Gonsalves C, Holland KD, et al. (May 2013). "Vagus nerve stimulation for medically refractory absence epilepsy". Seizure. 22 (4): 267–270. doi:10.1016/j.seizure.2013.01.008. PMID 23391567. S2CID 14917920.
Rolston JD, Englot DJ, Wang DD, Garcia PA, Chang EF (October 2015). "Corpus callosotomy versus vagus nerve stimulation for atonic seizures and drop attacks: A systematic review". Epilepsy & Behavior. 51: 13–17. doi:10.1016/j.yebeh.2015.06.001. PMC 5261864. PMID 26247311.
Dibué-Adjei M, Brigo F, Yamamoto T, Vonck K, Trinka E (September 2019). "Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review". Brain Stimulation. 12 (5): 1101–1110. doi:10.1016/j.brs.2019.05.011. PMID 31126871. S2CID 153310356.
Peng KP, Burish MJ (2023-08-01). "Management of cluster headache: Treatments and their mechanisms". Cephalalgia. 43 (8): 03331024231196808. doi:10.1177/03331024231196808. ISSN 0333-1024. PMID 37652457.
Silberstein SD, Mechtler LL, Kudrow DB, Calhoun AH, McClure C, Saper JR, et al. (2016). "Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study". Headache: The Journal of Head and Face Pain. 56 (8): 1317–1332. doi:10.1111/head.12896. ISSN 1526-4610. PMC 5113831. PMID 27593728.
Goadsby PJ, de Coo IF, Silver N, Tyagi A, Ahmed F, Gaul C, et al. (2018-04-01). "Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study". Cephalalgia. 38 (5): 959–969. doi:10.1177/0333102417744362. ISSN 0333-1024. PMC 5896689. PMID 29231763.
Carreno FR, Frazer A (July 2017). "Vagal Nerve Stimulation for Treatment-Resistant Depression". Neurotherapeutics. 14 (3): 716–727. doi:10.1007/s13311-017-0537-8. PMC 5509631. PMID 28585221.
Shao P, Li H, Jiang J, Guan Y, Chen X, Wang Y (2023). "Role of Vagus Nerve Stimulation in the Treatment of Chronic Pain". Neuroimmunomodulation. 30 (1): 167–183. doi:10.1159/000531626. PMC 10614462. PMID 37369181.
Capilupi MJ, Kerath SM, Becker LB (February 2020). "Vagus Nerve Stimulation and the Cardiovascular System". Cold Spring Harbor Perspectives in Medicine. 10 (2): a034173. doi:10.1101/cshperspect.a034173. PMC 6996447. PMID 31109966.
Andalib S, Divani AA, Ayata C, Baig S, Arsava EM, Topcuoglu MA, et al. (December 2023). "Vagus Nerve Stimulation in Ischemic Stroke". Current Neurology and Neuroscience Reports. 23 (12): 947–962. doi:10.1007/s11910-023-01323-w. PMC 10841711. PMID 38008851.
Liu CY, Russin J, Adelson DP, Jenkins A, Hilmi O, Brown B, et al. (November 2022). "Vagus nerve stimulation paired with rehabilitation for stroke: Implantation experience from the VNS-REHAB trial". Journal of Clinical Neuroscience. 105: 122–128. doi:10.1016/j.jocn.2022.09.013. PMID 36182812.
Englot DJ, Chang EF, Auguste KI (December 2011). "Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response". Journal of Neurosurgery. 115 (6): 1248–1255. doi:10.3171/2011.7.JNS11977. PMID 21838505.
Chrastina J, Novák Z, Zeman T, Kočvarová J, Pail M, Doležalová I, et al. (July 2018). "Single-center long-term results of vagus nerve stimulation for epilepsy: A 10-17 year follow-up study". Seizure. 59: 41–47. doi:10.1016/j.seizure.2018.04.022. PMID 29738985. S2CID 13700901.
Englot DJ, Rolston JD, Wright CW, Hassnain KH, Chang EF (September 2016). "Rates and Predictors of Seizure Freedom With Vagus Nerve Stimulation for Intractable Epilepsy". Neurosurgery. 79 (3): 345–353. doi:10.1227/NEU.0000000000001165. PMC 4884552. PMID 26645965.
Englot DJ, Hassnain KH, Rolston JD, Harward SC, Sinha SR, Haglund MM (January 2017). "Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data". Epilepsy & Behavior. 66: 4–9. doi:10.1016/j.yebeh.2016.10.005. PMC 5258831. PMID 27974275.
Ryvlin P, So EL, Gordon CM, Hesdorffer DC, Sperling MR, Devinsky O, et al. (March 2018). "Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapy". Epilepsia. 59 (3): 562–572. doi:10.1111/epi.14002. PMID 29336017. S2CID 3782079.
Englot DJ, Rolston JD, Wang DD, Hassnain KH, Gordon CM, Chang EF (November 2012). "Efficacy of vagus nerve stimulation in posttraumatic versus nontraumatic epilepsy". Journal of Neurosurgery. 117 (5): 970–977. doi:10.3171/2012.8.jns122. PMID 22978542.
Lam J, Williams M, Ashla M, Lee DJ (May 2021). "Cognitive outcomes following vagus nerve stimulation, responsive neurostimulation and deep brain stimulation for epilepsy: A systematic review". Epilepsy Research. 172: 106591. doi:10.1016/j.eplepsyres.2021.106591. PMID 33711711. S2CID 231956548.
Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D, et al. (October 2014). "Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children". Epilepsia. 55 (10): 1576–1584. doi:10.1111/epi.12762. PMID 25231724. S2CID 25790247.
Reif-Leonhard C, Reif A, Baune BT, Kavakbasi E (September 2022). "[Vagus nerve stimulation for difficult to treat depression]". Der Nervenarzt. 93 (9): 921–930. doi:10.1007/s00115-022-01282-6. PMC 9452433. PMID 35380222.
Rush AJ, Marangell LB, Sackeim HA, George MS, Brannan SK, Davis SM, et al. (September 2005). "Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial". Biological Psychiatry. 58 (5): 347–354. doi:10.1016/j.biopsych.2005.05.025. PMID 16139580.
Assenza G, Tombini M, Lanzone J, Ricci L, Di Lazzaro V, Casciato S, et al. (November 2020). "Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review". Neurological Sciences. 41 (11): 3075–3084. doi:10.1007/s10072-020-04479-2. hdl:11380/1207095. PMID 32524324. S2CID 219567684.
Aaronson ST, Carpenter LL, Conway CR, Reimherr FW, Lisanby SH, Schwartz TL, et al. (July 2013). "Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects". Brain Stimulation. 6 (4): 631–640. doi:10.1016/j.brs.2012.09.013. PMID 23122916.
Schachter SC (February 2004). "Vagus nerve stimulation: mood and cognitive effects". Epilepsy & Behavior. 5 Suppl 1: S56 – S59. doi:10.1016/j.yebeh.2003.11.007. PMID 14725847.
Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE (December 2000). "Vagus nerve stimulation is associated with mood improvements in epilepsy patients". Epilepsy Research. 42 (2–3): 203–210. doi:10.1016/s0920-1211(00)00181-9. PMID 11074193.
Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, Labar DR (April 2000). "A Pilot Study of Mood in Epilepsy Patients Treated with Vagus Nerve Stimulation". Epilepsy & Behavior. 1 (2): 93–99. doi:10.1006/ebeh.2000.0046. PMID 12609137.
Hoppe C, Helmstaedter C, Scherrmann J, Elger CE (August 2001). "Self-Reported Mood Changes following 6 Months of Vagus Nerve Stimulation in Epilepsy Patients". Epilepsy & Behavior. 2 (4): 335–342. doi:10.1006/ebeh.2001.0194. PMID 12609210. S2CID 22552070.
Fan JJ, Shan W, Wu JP, Wang Q (November 2019). "Research progress of vagus nerve stimulation in the treatment of epilepsy". CNS Neuroscience & Therapeutics. 25 (11): 1222–1228. doi:10.1111/cns.13209. PMC 6834923. PMID 31429206.
Ryvlin P, Gilliam FG, Nguyen DK, Colicchio G, Iudice A, Tinuper P, et al. (June 2014). "The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial". Epilepsia. 55 (6): 893–900. doi:10.1111/epi.12611. PMC 4283995. PMID 24754318.
Knorr C, Greuter L, Constantini S, Fried I, Kremer U, Datta AN, et al. (January 2021). "Subgroup analysis of seizure and cognitive outcome after vagal nerve stimulator implantation in children". Child's Nervous System. 37 (1): 243–252. doi:10.1007/s00381-020-04628-0. PMID 32361930. S2CID 218467172.
Tornero C, Pastor E, Garzando Md, Orduña J, Forner MJ, Bocigas I, et al. (2022-04-08). "Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I)". Frontiers in Neurology. 13. doi:10.3389/fneur.2022.820864. ISSN 1664-2295. PMC 9028764. PMID 35463130.
Khan MW, Ahmad M, Qudrat S, Afridi F, Khan NA, Afridi Z, et al. (2024-12-01). "Vagal nerve stimulation for the management of long COVID symptoms". Infectious Medicine. 3 (4): 100149. doi:10.1016/j.imj.2024.100149. ISSN 2772-431X. PMC 11638592. PMID 39678231.
Tarn J, Evans E, Traianos E, Collins A, Stylianou M, Parikh J, et al. (April 2023). "The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's Syndrome". Neuromodulation. 26 (3): 681–689. doi:10.1016/j.neurom.2022.08.461. PMID 37032583. S2CID 253172246.
Sahn B, Pascuma K, Kohn N, Tracey KJ, Markowitz JF (October 2023). "Transcutaneous auricular vagus nerve stimulation attenuates inflammatory bowel disease in children: a proof-of-concept clinical trial". Bioelectronic Medicine. 9 (1): 23. doi:10.1186/s42234-023-00124-3. PMC 10583463. PMID 37849000.
Mac CH, Tai HM, Huang SM, Peng HH, Sharma AK, Nguyen GL, et al. (May 2024). "Orally Ingested Self-Powered Stimulators for Targeted Gut-Brain Axis Electrostimulation to Treat Obesity and Metabolic Disorders". Advanced Materials. 36 (21): e2310351. Bibcode:2024AdM....3610351M. doi:10.1002/adma.202310351. PMID 38591658.
Fraschini M, Puligheddu M, Demuru M, Polizzi L, Maleci A, Tamburini G, et al. (March 2013). "VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy". Neuroscience Letters. 536: 14–18. doi:10.1016/j.neulet.2012.12.044. hdl:11380/1331383. PMID 23333601. S2CID 25790383.
Sangare A, Marchi A, Pruvost-Robieux E, Soufflet C, Crepon B, Ramdani C, et al. (December 2020). "The Effectiveness of Vagus Nerve Stimulation in Drug-Resistant Epilepsy Correlates with Vagus Nerve Stimulation-Induced Electroencephalography Desynchronization". Brain Connectivity. 10 (10): 566–577. doi:10.1089/brain.2020.0798. PMC 7757623. PMID 33073582.
Paudel YN, Shaikh MF, Shah S, Kumari Y, Othman I (October 2018). "Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy". European Journal of Pharmacology. 837: 145–155. doi:10.1016/j.ejphar.2018.08.020. PMID 30125565. S2CID 52048111.
Wang Y, Zhan G, Cai Z, Jiao B, Zhao Y, Li S, et al. (August 2021). "Vagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms". Neuroscience and Biobehavioral Reviews. 127: 37–53. doi:10.1016/j.neubiorev.2021.04.018. PMID 33894241. S2CID 233328858.
Manta S, El Mansari M, Debonnel G, Blier P (March 2013). "Electrophysiological and neurochemical effects of long-term vagus nerve stimulation on the rat monoaminergic systems". The International Journal of Neuropsychopharmacology. 16 (2): 459–470. doi:10.1017/s1461145712000387. PMID 22717062.
Furmaga H, Shah A, Frazer A (November 2011). "Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats". Biological Psychiatry. 70 (10): 937–945. doi:10.1016/j.biopsych.2011.07.020. PMID 21907323. S2CID 206101850.
Fornai F, Ruffoli R, Giorgi FS, Paparelli A (June 2011). "The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulation". The European Journal of Neuroscience. 33 (12): 2169–2178. doi:10.1111/j.1460-9568.2011.07707.x. ISSN 1460-9568. PMID 21535457.
Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, et al. (November 2020). "Locus coeruleus: a new look at the blue spot". Nature Reviews Neuroscience. 21 (11): 644–659. doi:10.1038/s41583-020-0360-9. ISSN 1471-0048. PMC 8991985. PMID 32943779.
Berger A, Vespa S, Dricot L, Dumoulin M, Iachim E, Doguet P, et al. (2021). "How Is the Norepinephrine System Involved in the Antiepileptic Effects of Vagus Nerve Stimulation?". Frontiers in Neuroscience. 15: 790943. doi:10.3389/fnins.2021.790943. ISSN 1662-4548. PMC 8675889. PMID 34924947.
Rodenkirch C, Carmel JB, Wang Q (2022-07-05). "Rapid Effects of Vagus Nerve Stimulation on Sensory Processing Through Activation of Neuromodulatory Systems". Frontiers in Neuroscience. 16. doi:10.3389/fnins.2022.922424. ISSN 1662-453X. PMC 9294458. PMID 35864985.
Breit S, Kupferberg A, Rogler G, Hasler G (2018). "Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders". Frontiers in Psychiatry. 9: 44. doi:10.3389/fpsyt.2018.00044. PMC 5859128. PMID 29593576.
Tarn J, Evans E, Traianos E, Collins A, Stylianou M, Parikh J, et al. (April 2023). "The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's Syndrome". Neuromodulation. 26 (3): 681–689. doi:10.1016/j.neurom.2022.08.461. PMID 37032583.
Faraji N, Payami B, Ebadpour N, Gorji A (2025-02-01). "Vagus nerve stimulation and gut microbiota interactions: A novel therapeutic avenue for neuropsychiatric disorders". Neuroscience & Biobehavioral Reviews. 169: 105990. doi:10.1016/j.neubiorev.2024.105990. ISSN 0149-7634. PMID 39716559.
Faraji N, Payami B, Ebadpour N, Gorji A (2025-02-01). "Vagus nerve stimulation and gut microbiota interactions: A novel therapeutic avenue for neuropsychiatric disorders". Neuroscience & Biobehavioral Reviews. 169: 105990. doi:10.1016/j.neubiorev.2024.105990. ISSN 0149-7634. PMID 39716559.
Révész D, Rydenhag B, Ben-Menachem E (July 2016). "Complications and safety of vagus nerve stimulation: 25 years of experience at a single center". Journal of Neurosurgery. Pediatrics. 18 (1): 97–104. doi:10.3171/2016.1.peds15534. PMID 27015521.
Révész D, Rydenhag B, Ben-Menachem E (July 2016). "Complications and safety of vagus nerve stimulation: 25 years of experience at a single center". Journal of Neurosurgery. Pediatrics. 18 (1): 97–104. doi:10.1016/j.ijporl.2023.111603. PMID 27015521.
Salvadé A, Ryvlin P, Rossetti AO (February 2018). "Impact of vagus nerve stimulation on sleep-related breathing disorders in adults with epilepsy". Epilepsy & Behavior. 79: 126–129. doi:10.1016/j.yebeh.2017.10.040. PMID 29287215. S2CID 46769980.
Aihua L, Lu S, Liping L, Xiuru W, Hua L, Yuping W (October 2014). "A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy". Epilepsy & Behavior. 39: 105–110. doi:10.1016/j.yebeh.2014.08.005. ISSN 1525-5069. PMID 25240121.
Edwards CA, Kouzani A, Lee KH, Ross EK (September 2017). "Neurostimulation Devices for the Treatment of Neurologic Disorders". Mayo Clinic Proceedings. 92 (9): 1427–1444. doi:10.1016/j.mayocp.2017.05.005. PMID 28870357.
Giordano F, Zicca A, Barba C, Guerrini R, Genitori L (April 2017). "Vagus nerve stimulation: Surgical technique of implantation and revision and related morbidity". Epilepsia. 58 Suppl 1 (Suppl 1): 85–90. doi:10.1111/epi.13678. PMID 28386925.
Butt MF, Albusoda A, Farmer AD, Aziz Q (April 2020). "The anatomical basis for transcutaneous auricular vagus nerve stimulation". Journal of Anatomy. 236 (4): 588–611. doi:10.1111/joa.13122. PMC 7083568. PMID 31742681.
Lanska DJ (February 2002). "J.L. Corning and vagal nerve stimulation for seizures in the 1880s". Neurology. 58 (3): 452–459. doi:10.1212/wnl.58.3.452. PMID 11839848.
George MS, Sackeim HA, Rush AJ, Marangell LB, Nahas Z, Husain MM, et al. (February 2000). "Vagus nerve stimulation: a new tool for brain research and therapy". Biological Psychiatry. 47 (4): 287–295. doi:10.1016/s0006-3223(99)00308-x. PMID 10686263. S2CID 14489190.
Zabara J (November 1992). "Inhibition of experimental seizures in canines by repetitive vagal stimulation". Epilepsia. 33 (6): 1005–1012. doi:10.1111/j.1528-1157.1992.tb01751.x. PMID 1464256. S2CID 19290172.
Penry JK, Dean JC (June 1990). "Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results". Epilepsia. 31 Suppl 2 (s2): S40 – S43. doi:10.1111/j.1528-1157.1990.tb05848.x. PMID 2121469. S2CID 32134763.
Groves DA, Brown VJ (May 2005). "Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects". Neuroscience and Biobehavioral Reviews. 29 (3): 493–500. doi:10.1016/j.neubiorev.2005.01.004. PMID 15820552. S2CID 3021573.
de Lartigue G (October 2016). "Role of the vagus nerve in the development and treatment of diet-induced obesity". The Journal of Physiology. 594 (20): 5791–5815. doi:10.1113/JP271538. PMC 5063945. PMID 26959077.
Göbel CH, Tronnier VM, Münte TF (December 2017). "Brain stimulation in obesity". International Journal of Obesity. 41 (12): 1721–1727. doi:10.1038/ijo.2017.150. PMID 28663570. S2CID 20426017.
Herremans SC, Baeken C (September 2012). "The current perspective of neuromodulation techniques in the treatment of alcohol addiction: a systematic review". Psychiatria Danubina. 24 Suppl 1 (suppl 1): S14 – S20. PMID 22945180.
Abraham WT, Smith SA (February 2013). "Devices in the management of advanced, chronic heart failure". Nature Reviews. Cardiology. 10 (2): 98–110. doi:10.1038/nrcardio.2012.178. PMC 3753073. PMID 23229137.
Sabbah HN (August 2011). "Electrical vagus nerve stimulation for the treatment of chronic heart failure". Cleveland Clinic Journal of Medicine. 78 Suppl 1 (1): S24 – S29. doi:10.3949/ccjm.78.s1.04. PMC 3817894. PMID 21972326.
Koopman FA, van Maanen MA, Vervoordeldonk MJ, Tak PP (July 2017). "Balancing the autonomic nervous system to reduce inflammation in rheumatoid arthritis". Journal of Internal Medicine. 282 (1): 64–75. doi:10.1111/joim.12626. PMID 28547815.
Bonaz B, Sinniger V, Pellissier S (2021). "Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases". Frontiers in Neuroscience. 15: 650971. doi:10.3389/fnins.2021.650971. PMC 8019822. PMID 33828455.
Payne SC, Furness JB, Burns O, Sedo A, Hyakumura T, Shepherd RK, et al. (2019). "Anti-inflammatory Effects of Abdominal Vagus Nerve Stimulation on Experimental Intestinal Inflammation". Frontiers in Neuroscience. 13: 418. doi:10.3389/fnins.2019.00418. PMC 6517481. PMID 31133776.
Merrill CA, Jonsson MA, Minthon L, Ejnell H, C-son Silander H, Blennow K, et al. (August 2006). "Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year". The Journal of Clinical Psychiatry. 67 (8): 1171–1178. doi:10.4088/jcp.v67n0801. PMID 16965193.
Broncel A, Bocian R, Kłos-Wojtczak P, Kulbat-Warycha K, Konopacki J (February 2020). "Vagal nerve stimulation as a promising tool in the improvement of cognitive disorders". Brain Research Bulletin. 155: 37–47. doi:10.1016/j.brainresbull.2019.11.011. PMID 31790720. S2CID 208344249.
Gierthmuehlen M, Plachta DT (February 2016). "Effect of selective vagal nerve stimulation on blood pressure, heart rate and respiratory rate in rats under metoprolol medication". Hypertension Research. 39 (2): 79–87. doi:10.1038/hr.2015.122. PMID 26581776. S2CID 21184892.
Annoni EM, Van Helden D, Guo Y, Levac B, Libbus I, KenKnight BH, et al. (31 January 2019). "Chronic Low-Level Vagus Nerve Stimulation Improves Long-Term Survival in Salt-Sensitive Hypertensive Rats". Frontiers in Physiology. 10: 25. doi:10.3389/fphys.2019.00025. PMC 6365472. PMID 30766489.
Chakravarthy K, Chaudhry H, Williams K, Christo PJ (December 2015). "Review of the Uses of Vagal Nerve Stimulation in Chronic Pain Management". Current Pain and Headache Reports. 19 (12): 54. doi:10.1007/s11916-015-0528-6. PMID 26493698. S2CID 8117776.
Johnson RL, Wilson CG (2018). "A review of vagus nerve stimulation as a therapeutic intervention". Journal of Inflammation Research. 11: 203–213. doi:10.2147/JIR.S163248. PMC 5961632. PMID 29844694.
Puledda F, Goadsby PJ (April 2017). "An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine". Headache. 57 (4): 685–691. doi:10.1111/head.13069. PMID 28295242. S2CID 205161411.
Yesiltepe M, Cimen B, Sara Y (September 2022). "Effects of chronic vagal nerve stimulation in the treatment of β-amyloid-induced neuropsychiatric symptoms". European Journal of Pharmacology. 931: 175179. doi:10.1016/j.ejphar.2022.175179. PMID 35973478. S2CID 251558829.

ncbi.nlm.nih.gov

Badran BW, Austelle CW (January 2022). "The Future Is Noninvasive: A Brief Review of the Evolution and Clinical Utility of Vagus Nerve Stimulation". Focus. 20 (1): 3–7. doi:10.1176/appi.focus.20210023. PMC 9063597. PMID 35746934.
Badran BW, Austelle CW (January 2022). "The Future Is Noninvasive: A Brief Review of the Evolution and Clinical Utility of Vagus Nerve Stimulation". Focus. 20 (1): 3–7. doi:10.1176/appi.focus.20210023. PMC 9063597. PMID 35746934.
Johnson RL, Wilson CG (May 2018). "A review of vagus nerve stimulation as a therapeutic intervention". Journal of Inflammation Research. 11: 203–213. doi:10.2147/JIR.S163248. PMC 5961632. PMID 29844694.
Panebianco M, Rigby A, Marson AG (July 2022). "Vagus nerve stimulation for focal seizures". The Cochrane Database of Systematic Reviews. 2022 (7): CD002896. doi:10.1002/14651858.CD002896.pub3. PMC 9281624. PMID 35833911.
Howland RH (June 2014). "Vagus Nerve Stimulation". Current Behavioral Neuroscience Reports. 1 (2): 64–73. doi:10.1007/s40473-014-0010-5. PMC 4017164. PMID 24834378.
Morris GL, Gloss D, Buchhalter J, Mack KJ, Nickels K, Harden C (October 2013). "Evidence-based guideline update: vagus nerve stimulation for the treatment of epilepsy: report of the Guideline Development Subcommittee of the American Academy of Neurology". Neurology. 81 (16): 1453–1459. doi:10.1212/wnl.0b013e3182a393d1. PMC 3806910. PMID 23986299.
Braakman HM, Creemers J, Hilkman DM, Klinkenberg S, Koudijs SM, Debeij-van Hall M, et al. (2018). "Improved seizure control and regaining cognitive milestones after vagus nerve stimulation revision surgery in Lennox-Gastaut syndrome". Epilepsy & Behavior Case Reports. 10: 111–113. doi:10.1016/j.ebcr.2018.08.002. PMC 6197149. PMID 30364578.
Rolston JD, Englot DJ, Wang DD, Garcia PA, Chang EF (October 2015). "Corpus callosotomy versus vagus nerve stimulation for atonic seizures and drop attacks: A systematic review". Epilepsy & Behavior. 51: 13–17. doi:10.1016/j.yebeh.2015.06.001. PMC 5261864. PMID 26247311.
Silberstein SD, Mechtler LL, Kudrow DB, Calhoun AH, McClure C, Saper JR, et al. (2016). "Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study". Headache: The Journal of Head and Face Pain. 56 (8): 1317–1332. doi:10.1111/head.12896. ISSN 1526-4610. PMC 5113831. PMID 27593728.
Goadsby PJ, de Coo IF, Silver N, Tyagi A, Ahmed F, Gaul C, et al. (2018-04-01). "Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study". Cephalalgia. 38 (5): 959–969. doi:10.1177/0333102417744362. ISSN 0333-1024. PMC 5896689. PMID 29231763.
Carreno FR, Frazer A (July 2017). "Vagal Nerve Stimulation for Treatment-Resistant Depression". Neurotherapeutics. 14 (3): 716–727. doi:10.1007/s13311-017-0537-8. PMC 5509631. PMID 28585221.
Shao P, Li H, Jiang J, Guan Y, Chen X, Wang Y (2023). "Role of Vagus Nerve Stimulation in the Treatment of Chronic Pain". Neuroimmunomodulation. 30 (1): 167–183. doi:10.1159/000531626. PMC 10614462. PMID 37369181.
Capilupi MJ, Kerath SM, Becker LB (February 2020). "Vagus Nerve Stimulation and the Cardiovascular System". Cold Spring Harbor Perspectives in Medicine. 10 (2): a034173. doi:10.1101/cshperspect.a034173. PMC 6996447. PMID 31109966.
Andalib S, Divani AA, Ayata C, Baig S, Arsava EM, Topcuoglu MA, et al. (December 2023). "Vagus Nerve Stimulation in Ischemic Stroke". Current Neurology and Neuroscience Reports. 23 (12): 947–962. doi:10.1007/s11910-023-01323-w. PMC 10841711. PMID 38008851.
Englot DJ, Rolston JD, Wright CW, Hassnain KH, Chang EF (September 2016). "Rates and Predictors of Seizure Freedom With Vagus Nerve Stimulation for Intractable Epilepsy". Neurosurgery. 79 (3): 345–353. doi:10.1227/NEU.0000000000001165. PMC 4884552. PMID 26645965.
Englot DJ, Hassnain KH, Rolston JD, Harward SC, Sinha SR, Haglund MM (January 2017). "Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data". Epilepsy & Behavior. 66: 4–9. doi:10.1016/j.yebeh.2016.10.005. PMC 5258831. PMID 27974275.
Reif-Leonhard C, Reif A, Baune BT, Kavakbasi E (September 2022). "[Vagus nerve stimulation for difficult to treat depression]". Der Nervenarzt. 93 (9): 921–930. doi:10.1007/s00115-022-01282-6. PMC 9452433. PMID 35380222.
Fan JJ, Shan W, Wu JP, Wang Q (November 2019). "Research progress of vagus nerve stimulation in the treatment of epilepsy". CNS Neuroscience & Therapeutics. 25 (11): 1222–1228. doi:10.1111/cns.13209. PMC 6834923. PMID 31429206.
Ryvlin P, Gilliam FG, Nguyen DK, Colicchio G, Iudice A, Tinuper P, et al. (June 2014). "The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: the PuLsE (Open Prospective Randomized Long-term Effectiveness) trial". Epilepsia. 55 (6): 893–900. doi:10.1111/epi.12611. PMC 4283995. PMID 24754318.
Tornero C, Pastor E, Garzando Md, Orduña J, Forner MJ, Bocigas I, et al. (2022-04-08). "Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I)". Frontiers in Neurology. 13. doi:10.3389/fneur.2022.820864. ISSN 1664-2295. PMC 9028764. PMID 35463130.
Khan MW, Ahmad M, Qudrat S, Afridi F, Khan NA, Afridi Z, et al. (2024-12-01). "Vagal nerve stimulation for the management of long COVID symptoms". Infectious Medicine. 3 (4): 100149. doi:10.1016/j.imj.2024.100149. ISSN 2772-431X. PMC 11638592. PMID 39678231.
Sahn B, Pascuma K, Kohn N, Tracey KJ, Markowitz JF (October 2023). "Transcutaneous auricular vagus nerve stimulation attenuates inflammatory bowel disease in children: a proof-of-concept clinical trial". Bioelectronic Medicine. 9 (1): 23. doi:10.1186/s42234-023-00124-3. PMC 10583463. PMID 37849000.
Sangare A, Marchi A, Pruvost-Robieux E, Soufflet C, Crepon B, Ramdani C, et al. (December 2020). "The Effectiveness of Vagus Nerve Stimulation in Drug-Resistant Epilepsy Correlates with Vagus Nerve Stimulation-Induced Electroencephalography Desynchronization". Brain Connectivity. 10 (10): 566–577. doi:10.1089/brain.2020.0798. PMC 7757623. PMID 33073582.
Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, et al. (November 2020). "Locus coeruleus: a new look at the blue spot". Nature Reviews Neuroscience. 21 (11): 644–659. doi:10.1038/s41583-020-0360-9. ISSN 1471-0048. PMC 8991985. PMID 32943779.
Berger A, Vespa S, Dricot L, Dumoulin M, Iachim E, Doguet P, et al. (2021). "How Is the Norepinephrine System Involved in the Antiepileptic Effects of Vagus Nerve Stimulation?". Frontiers in Neuroscience. 15: 790943. doi:10.3389/fnins.2021.790943. ISSN 1662-4548. PMC 8675889. PMID 34924947.
Rodenkirch C, Carmel JB, Wang Q (2022-07-05). "Rapid Effects of Vagus Nerve Stimulation on Sensory Processing Through Activation of Neuromodulatory Systems". Frontiers in Neuroscience. 16. doi:10.3389/fnins.2022.922424. ISSN 1662-453X. PMC 9294458. PMID 35864985.
Breit S, Kupferberg A, Rogler G, Hasler G (2018). "Vagus Nerve as Modulator of the Brain-Gut Axis in Psychiatric and Inflammatory Disorders". Frontiers in Psychiatry. 9: 44. doi:10.3389/fpsyt.2018.00044. PMC 5859128. PMID 29593576.
Butt MF, Albusoda A, Farmer AD, Aziz Q (April 2020). "The anatomical basis for transcutaneous auricular vagus nerve stimulation". Journal of Anatomy. 236 (4): 588–611. doi:10.1111/joa.13122. PMC 7083568. PMID 31742681.
de Lartigue G (October 2016). "Role of the vagus nerve in the development and treatment of diet-induced obesity". The Journal of Physiology. 594 (20): 5791–5815. doi:10.1113/JP271538. PMC 5063945. PMID 26959077.
Abraham WT, Smith SA (February 2013). "Devices in the management of advanced, chronic heart failure". Nature Reviews. Cardiology. 10 (2): 98–110. doi:10.1038/nrcardio.2012.178. PMC 3753073. PMID 23229137.
Sabbah HN (August 2011). "Electrical vagus nerve stimulation for the treatment of chronic heart failure". Cleveland Clinic Journal of Medicine. 78 Suppl 1 (1): S24 – S29. doi:10.3949/ccjm.78.s1.04. PMC 3817894. PMID 21972326.
Bonaz B, Sinniger V, Pellissier S (2021). "Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases". Frontiers in Neuroscience. 15: 650971. doi:10.3389/fnins.2021.650971. PMC 8019822. PMID 33828455.
Payne SC, Furness JB, Burns O, Sedo A, Hyakumura T, Shepherd RK, et al. (2019). "Anti-inflammatory Effects of Abdominal Vagus Nerve Stimulation on Experimental Intestinal Inflammation". Frontiers in Neuroscience. 13: 418. doi:10.3389/fnins.2019.00418. PMC 6517481. PMID 31133776.
Annoni EM, Van Helden D, Guo Y, Levac B, Libbus I, KenKnight BH, et al. (31 January 2019). "Chronic Low-Level Vagus Nerve Stimulation Improves Long-Term Survival in Salt-Sensitive Hypertensive Rats". Frontiers in Physiology. 10: 25. doi:10.3389/fphys.2019.00025. PMC 6365472. PMID 30766489.
Johnson RL, Wilson CG (2018). "A review of vagus nerve stimulation as a therapeutic intervention". Journal of Inflammation Research. 11: 203–213. doi:10.2147/JIR.S163248. PMC 5961632. PMID 29844694.

sciencedirect.com

Faraji N, Payami B, Ebadpour N, Gorji A (2025-02-01). "Vagus nerve stimulation and gut microbiota interactions: A novel therapeutic avenue for neuropsychiatric disorders". Neuroscience & Biobehavioral Reviews. 169: 105990. doi:10.1016/j.neubiorev.2024.105990. ISSN 0149-7634. PMID 39716559.
Faraji N, Payami B, Ebadpour N, Gorji A (2025-02-01). "Vagus nerve stimulation and gut microbiota interactions: A novel therapeutic avenue for neuropsychiatric disorders". Neuroscience & Biobehavioral Reviews. 169: 105990. doi:10.1016/j.neubiorev.2024.105990. ISSN 0149-7634. PMID 39716559.

scientificamerican.com

Fox D (4 May 2017), Can Zapping the Vagus Nerve Jump-Start Immunity?: An experimental procedure is exposing links between nervous and immune systems, Scientific American

semanticscholar.org

api.semanticscholar.org

Wheless JW, Gienapp AJ, Ryvlin P (November 2018). "Vagus nerve stimulation (VNS) therapy update". Epilepsy & Behavior. 88S: 2–10. doi:10.1016/j.yebeh.2018.06.032. PMID 30017839. S2CID 51679627.
Fisher RS, Handforth A (September 1999). "Reassessment: vagus nerve stimulation for epilepsy: a report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology". Neurology. 53 (4): 666–669. doi:10.1212/wnl.53.4.666. PMID 10489023. S2CID 20845641.
Helmers SL, Duh MS, Guérin A, Sarda SP, Samuelson TM, Bunker MT, et al. (October 2011). "Clinical and economic impact of vagus nerve stimulation therapy in patients with drug-resistant epilepsy". Epilepsy & Behavior. 22 (2): 370–375. doi:10.1016/j.yebeh.2011.07.020. PMID 21872534. S2CID 7869407.
Grioni D, Landi A (January 2019). "Does Vagal Nerve Stimulation Treat Drug-Resistant Epilepsy in Patients with Tuberous Sclerosis Complex?". World Neurosurgery. 121: 251–253. doi:10.1016/j.wneu.2018.10.077. PMID 30347295. S2CID 53034756.
Arya R, Greiner HM, Lewis A, Mangano FT, Gonsalves C, Holland KD, et al. (May 2013). "Vagus nerve stimulation for medically refractory absence epilepsy". Seizure. 22 (4): 267–270. doi:10.1016/j.seizure.2013.01.008. PMID 23391567. S2CID 14917920.
Dibué-Adjei M, Brigo F, Yamamoto T, Vonck K, Trinka E (September 2019). "Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review". Brain Stimulation. 12 (5): 1101–1110. doi:10.1016/j.brs.2019.05.011. PMID 31126871. S2CID 153310356.
Chrastina J, Novák Z, Zeman T, Kočvarová J, Pail M, Doležalová I, et al. (July 2018). "Single-center long-term results of vagus nerve stimulation for epilepsy: A 10-17 year follow-up study". Seizure. 59: 41–47. doi:10.1016/j.seizure.2018.04.022. PMID 29738985. S2CID 13700901.
Ryvlin P, So EL, Gordon CM, Hesdorffer DC, Sperling MR, Devinsky O, et al. (March 2018). "Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapy". Epilepsia. 59 (3): 562–572. doi:10.1111/epi.14002. PMID 29336017. S2CID 3782079.
Lam J, Williams M, Ashla M, Lee DJ (May 2021). "Cognitive outcomes following vagus nerve stimulation, responsive neurostimulation and deep brain stimulation for epilepsy: A systematic review". Epilepsy Research. 172: 106591. doi:10.1016/j.eplepsyres.2021.106591. PMID 33711711. S2CID 231956548.
Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D, et al. (October 2014). "Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children". Epilepsia. 55 (10): 1576–1584. doi:10.1111/epi.12762. PMID 25231724. S2CID 25790247.
Assenza G, Tombini M, Lanzone J, Ricci L, Di Lazzaro V, Casciato S, et al. (November 2020). "Antidepressant effect of vagal nerve stimulation in epilepsy patients: a systematic review". Neurological Sciences. 41 (11): 3075–3084. doi:10.1007/s10072-020-04479-2. hdl:11380/1207095. PMID 32524324. S2CID 219567684.
Hoppe C, Helmstaedter C, Scherrmann J, Elger CE (August 2001). "Self-Reported Mood Changes following 6 Months of Vagus Nerve Stimulation in Epilepsy Patients". Epilepsy & Behavior. 2 (4): 335–342. doi:10.1006/ebeh.2001.0194. PMID 12609210. S2CID 22552070.
Knorr C, Greuter L, Constantini S, Fried I, Kremer U, Datta AN, et al. (January 2021). "Subgroup analysis of seizure and cognitive outcome after vagal nerve stimulator implantation in children". Child's Nervous System. 37 (1): 243–252. doi:10.1007/s00381-020-04628-0. PMID 32361930. S2CID 218467172.
Tarn J, Evans E, Traianos E, Collins A, Stylianou M, Parikh J, et al. (April 2023). "The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's Syndrome". Neuromodulation. 26 (3): 681–689. doi:10.1016/j.neurom.2022.08.461. PMID 37032583. S2CID 253172246.
Fraschini M, Puligheddu M, Demuru M, Polizzi L, Maleci A, Tamburini G, et al. (March 2013). "VNS induced desynchronization in gamma bands correlates with positive clinical outcome in temporal lobe pharmacoresistant epilepsy". Neuroscience Letters. 536: 14–18. doi:10.1016/j.neulet.2012.12.044. hdl:11380/1331383. PMID 23333601. S2CID 25790383.
Joseph NM, Steffan P, Becker D, Wernovsky M, Datta P, Ernst L (June 2022). "Effects of VNS stimulation on electrocorticography in patients with dual neuro- stimulation devices". Journal of Neurology, Neurosurgery & Psychiatry. 93 (6): A3.3–A4. doi:10.1136/jnnp-2022-abn.9. S2CID 249067601.
Paudel YN, Shaikh MF, Shah S, Kumari Y, Othman I (October 2018). "Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy". European Journal of Pharmacology. 837: 145–155. doi:10.1016/j.ejphar.2018.08.020. PMID 30125565. S2CID 52048111.
Wang Y, Zhan G, Cai Z, Jiao B, Zhao Y, Li S, et al. (August 2021). "Vagus nerve stimulation in brain diseases: Therapeutic applications and biological mechanisms". Neuroscience and Biobehavioral Reviews. 127: 37–53. doi:10.1016/j.neubiorev.2021.04.018. PMID 33894241. S2CID 233328858.
Furmaga H, Shah A, Frazer A (November 2011). "Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats". Biological Psychiatry. 70 (10): 937–945. doi:10.1016/j.biopsych.2011.07.020. PMID 21907323. S2CID 206101850.
Salvadé A, Ryvlin P, Rossetti AO (February 2018). "Impact of vagus nerve stimulation on sleep-related breathing disorders in adults with epilepsy". Epilepsy & Behavior. 79: 126–129. doi:10.1016/j.yebeh.2017.10.040. PMID 29287215. S2CID 46769980.
George MS, Sackeim HA, Rush AJ, Marangell LB, Nahas Z, Husain MM, et al. (February 2000). "Vagus nerve stimulation: a new tool for brain research and therapy". Biological Psychiatry. 47 (4): 287–295. doi:10.1016/s0006-3223(99)00308-x. PMID 10686263. S2CID 14489190.
Zabara J (November 1992). "Inhibition of experimental seizures in canines by repetitive vagal stimulation". Epilepsia. 33 (6): 1005–1012. doi:10.1111/j.1528-1157.1992.tb01751.x. PMID 1464256. S2CID 19290172.
Penry JK, Dean JC (June 1990). "Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results". Epilepsia. 31 Suppl 2 (s2): S40 – S43. doi:10.1111/j.1528-1157.1990.tb05848.x. PMID 2121469. S2CID 32134763.
Groves DA, Brown VJ (May 2005). "Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects". Neuroscience and Biobehavioral Reviews. 29 (3): 493–500. doi:10.1016/j.neubiorev.2005.01.004. PMID 15820552. S2CID 3021573.
Göbel CH, Tronnier VM, Münte TF (December 2017). "Brain stimulation in obesity". International Journal of Obesity. 41 (12): 1721–1727. doi:10.1038/ijo.2017.150. PMID 28663570. S2CID 20426017.
Broncel A, Bocian R, Kłos-Wojtczak P, Kulbat-Warycha K, Konopacki J (February 2020). "Vagal nerve stimulation as a promising tool in the improvement of cognitive disorders". Brain Research Bulletin. 155: 37–47. doi:10.1016/j.brainresbull.2019.11.011. PMID 31790720. S2CID 208344249.
Gierthmuehlen M, Plachta DT (February 2016). "Effect of selective vagal nerve stimulation on blood pressure, heart rate and respiratory rate in rats under metoprolol medication". Hypertension Research. 39 (2): 79–87. doi:10.1038/hr.2015.122. PMID 26581776. S2CID 21184892.
Chakravarthy K, Chaudhry H, Williams K, Christo PJ (December 2015). "Review of the Uses of Vagal Nerve Stimulation in Chronic Pain Management". Current Pain and Headache Reports. 19 (12): 54. doi:10.1007/s11916-015-0528-6. PMID 26493698. S2CID 8117776.
Puledda F, Goadsby PJ (April 2017). "An Update on Non-Pharmacological Neuromodulation for the Acute and Preventive Treatment of Migraine". Headache. 57 (4): 685–691. doi:10.1111/head.13069. PMID 28295242. S2CID 205161411.
Yesiltepe M, Cimen B, Sara Y (September 2022). "Effects of chronic vagal nerve stimulation in the treatment of β-amyloid-induced neuropsychiatric symptoms". European Journal of Pharmacology. 931: 175179. doi:10.1016/j.ejphar.2022.175179. PMID 35973478. S2CID 251558829.

srce.hr

hrcak.srce.hr

Herremans SC, Baeken C (September 2012). "The current perspective of neuromodulation techniques in the treatment of alcohol addiction: a systematic review". Psychiatria Danubina. 24 Suppl 1 (suppl 1): S14 – S20. PMID 22945180.

unil.ch

serval.unil.ch

Salvadé A, Ryvlin P, Rossetti AO (February 2018). "Impact of vagus nerve stimulation on sleep-related breathing disorders in adults with epilepsy". Epilepsy & Behavior. 79: 126–129. doi:10.1016/j.yebeh.2017.10.040. PMID 29287215. S2CID 46769980.

washingtonpost.com

Squires S (24 March 1998). "Washingtonpost.com: Nation". The Washington Post. p. Z07.

web.archive.org

"FDA Approves First-of-Its-Kind Stroke Rehabilitation System". Food and Drug Administration. 31 August 2021. Archived from the original on August 27, 2021.
fda.gov
"GammaCore 510(k) Premarket Notification". FDA. Archived from the original on November 11, 2020. Retrieved 6 June 2018.

worldcat.org

search.worldcat.org

Peng KP, Burish MJ (2023-08-01). "Management of cluster headache: Treatments and their mechanisms". Cephalalgia. 43 (8): 03331024231196808. doi:10.1177/03331024231196808. ISSN 0333-1024. PMID 37652457.
Silberstein SD, Mechtler LL, Kudrow DB, Calhoun AH, McClure C, Saper JR, et al. (2016). "Non–Invasive Vagus Nerve Stimulation for the ACute Treatment of Cluster Headache: Findings From the Randomized, Double-Blind, Sham-Controlled ACT1 Study". Headache: The Journal of Head and Face Pain. 56 (8): 1317–1332. doi:10.1111/head.12896. ISSN 1526-4610. PMC 5113831. PMID 27593728.
Goadsby PJ, de Coo IF, Silver N, Tyagi A, Ahmed F, Gaul C, et al. (2018-04-01). "Non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A randomized, double-blind, sham-controlled ACT2 study". Cephalalgia. 38 (5): 959–969. doi:10.1177/0333102417744362. ISSN 0333-1024. PMC 5896689. PMID 29231763.
Tornero C, Pastor E, Garzando Md, Orduña J, Forner MJ, Bocigas I, et al. (2022-04-08). "Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I)". Frontiers in Neurology. 13. doi:10.3389/fneur.2022.820864. ISSN 1664-2295. PMC 9028764. PMID 35463130.
Khan MW, Ahmad M, Qudrat S, Afridi F, Khan NA, Afridi Z, et al. (2024-12-01). "Vagal nerve stimulation for the management of long COVID symptoms". Infectious Medicine. 3 (4): 100149. doi:10.1016/j.imj.2024.100149. ISSN 2772-431X. PMC 11638592. PMID 39678231.
Fornai F, Ruffoli R, Giorgi FS, Paparelli A (June 2011). "The role of locus coeruleus in the antiepileptic activity induced by vagus nerve stimulation". The European Journal of Neuroscience. 33 (12): 2169–2178. doi:10.1111/j.1460-9568.2011.07707.x. ISSN 1460-9568. PMID 21535457.
Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, et al. (November 2020). "Locus coeruleus: a new look at the blue spot". Nature Reviews Neuroscience. 21 (11): 644–659. doi:10.1038/s41583-020-0360-9. ISSN 1471-0048. PMC 8991985. PMID 32943779.
Berger A, Vespa S, Dricot L, Dumoulin M, Iachim E, Doguet P, et al. (2021). "How Is the Norepinephrine System Involved in the Antiepileptic Effects of Vagus Nerve Stimulation?". Frontiers in Neuroscience. 15: 790943. doi:10.3389/fnins.2021.790943. ISSN 1662-4548. PMC 8675889. PMID 34924947.
Rodenkirch C, Carmel JB, Wang Q (2022-07-05). "Rapid Effects of Vagus Nerve Stimulation on Sensory Processing Through Activation of Neuromodulatory Systems". Frontiers in Neuroscience. 16. doi:10.3389/fnins.2022.922424. ISSN 1662-453X. PMC 9294458. PMID 35864985.
Faraji N, Payami B, Ebadpour N, Gorji A (2025-02-01). "Vagus nerve stimulation and gut microbiota interactions: A novel therapeutic avenue for neuropsychiatric disorders". Neuroscience & Biobehavioral Reviews. 169: 105990. doi:10.1016/j.neubiorev.2024.105990. ISSN 0149-7634. PMID 39716559.
Faraji N, Payami B, Ebadpour N, Gorji A (2025-02-01). "Vagus nerve stimulation and gut microbiota interactions: A novel therapeutic avenue for neuropsychiatric disorders". Neuroscience & Biobehavioral Reviews. 169: 105990. doi:10.1016/j.neubiorev.2024.105990. ISSN 0149-7634. PMID 39716559.
Aihua L, Lu S, Liping L, Xiuru W, Hua L, Yuping W (October 2014). "A controlled trial of transcutaneous vagus nerve stimulation for the treatment of pharmacoresistant epilepsy". Epilepsy & Behavior. 39: 105–110. doi:10.1016/j.yebeh.2014.08.005. ISSN 1525-5069. PMID 25240121.